rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Louis J. Lavigne Jr.

Director

Company insider

Files Form 4 as: Director, Alector; Director, Zynga; Director, Accuray; Director, DocuSign; Director, Assertio Therapeutics; Director, NovoCure; Director, Allergan; Director, Bmc Software.

In numbers

Trades disclosed
204
Buys
0
Sells
3
Bought
$0
Sold
$8.6M
Companies
11
Companies where not an officer
11
First trade
2 May 2006
Last trade
17 Jun 2026
Last filed
17 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ALEC AlectorDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
ZyngaDirector · last 23 May 20220 buys · 0 sells
ARAY AccurayDirector · Medical Devices · last 30 Nov 20200 buys · 0 sells
DOCU DocuSignDirector · Software · last 17 Jun 20190 buys · 0 sells
Assertio TherapeuticsDirector · last 7 May 20190 buys · 0 sells
NVCR NovoCureDirector · Medical Devices · last 31 May 20180 buys · 0 sells
AllerganDirector · last 17 Mar 20150 buys · 3 sells
Bmc SoftwareDirector · last 10 Sep 20130 buys · 0 sells
KyphonDirector · last 2 Nov 20070 buys · 0 sells
Arena PharmaceuticalsDirector · last 28 Jul 20060 buys · 0 sells
EQIX EquinixDirector · REITs · last 8 Jun 20060 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 17 Jun 2026ALEC AlectorBiotechnologySEC FORM 4 Code A—28,700 at $0.00filing
17 Jun 2026filed 17 Jun 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—9,450 at $0.00filing
17 Jun 2026filed 17 Jun 2026ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—9,450 at $0.00filing
17 Jun 2026filed 17 Jun 2026ALEC AlectorBiotechnologySEC FORM 4 Code A—28,700 at $0.00filing
11 Jun 2025filed 12 Jun 2025ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—9,450 at $0.00filing
11 Jun 2025filed 12 Jun 2025ALEC AlectorBiotechnologySEC FORM 4 Code A—28,700 at $0.00filing
12 Jun 2024filed 12 Jun 2024ALEC AlectorBiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
14 Jun 2023filed 15 Jun 2023ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—12,360 at $0.00filing
14 Jun 2023filed 15 Jun 2023ALEC AlectorBiotechnologySEC FORM 4 Code A—26,250 at $0.00filing
16 Jun 2022filed 21 Jun 2022ALEC Alectoroption or derivative · BiotechnologySEC FORM 4 Code A—18,918 at $0.00filing
16 Jun 2022filed 21 Jun 2022ALEC AlectorBiotechnologySEC FORM 4 Code A—9,459 at $0.00filing
23 May 2022filed 24 May 2022ZyngaSEC FORM 4 Code D—5,548filing
23 May 2022filed 24 May 2022ZyngaSEC FORM 4 Code D—278,516filing
17 May 2022filed 19 May 2022Zyngaoption or derivativeSEC FORM 4 Code M—5,548 at $0.00filing
17 May 2022filed 19 May 2022ZyngaSEC FORM 4 Code M—5,548 at $0.00filing
17 Feb 2022filed 22 Feb 2022Zyngaoption or derivativeSEC FORM 4 Code M—5,547 at $0.00filing
17 Feb 2022filed 22 Feb 2022ZyngaSEC FORM 4 Code M—5,547 at $0.00filing
17 Nov 2021filed 17 Nov 2021Zyngaoption or derivativeSEC FORM 4 Code M—5,547 at $0.00filing
17 Nov 2021filed 17 Nov 2021ZyngaSEC FORM 4 Code M—5,547 at $0.00filing
17 Aug 2021filed 18 Aug 2021Zyngaoption or derivativeSEC FORM 4 Code M—5,547 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Arnon RosenthalChief Executive Officer · Chief Executive Officer at Alector, filing Form 4 there in the last year
Neil Lindsay BerkleyCFO & Chief Business Officer · CFO & Chief Business Officer at Alector, filing Form 4 there in the last year
Grace Wong-SaradPrincipal Accounting Officer · Principal Accounting Officer at Alector, filing Form 4 there in the last year
Kristine YaffeDirector · Director at Alector, filing Form 4 there in the last year
Errol B. DesouzaDirector · Director at Alector, filing Form 4 there in the last year